300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Honduras
Iceland
Grenada
Liechtenstein
Lebanon
Lithuania
Cambodia
Slovenia
Mongolia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
iSelect Fund, VC Fund

iSelect Fund

VC Fund

St Louis, United States

iSelect Fund is a VC fund in St Louis focused on Biotechnology and Health Care. From spiraling healthcare costs, to the rise of chronic diseases, to feeding a growing global population, the world is facing a complex web of interrelated challenges. iSelect was created to help solve these problems, connecting investors with the innovative companies that are fixing the food and health systems while opening up access to investment opportunities that are making a real impact on the future of our world.

Total investments:
118
Last investment:
Lead investor:
14%
Fund size:
$3.8M
Last fund:

Last updated:

Industries iSelect Fund invests in

BiotechnologyHealth CareAgricultureSoftwareAgTech

Stages iSelect Fund invests in

SeedSeries AVenture - Series UnknownSeries BSeries C

Countries iSelect Fund invests in

United StatesCanadaAustraliaNew Zealand

Round sizes

Seed $500k–$9MSeries A $600k–$41MVenture - Series Unknown $1.2M–$24M

Contacts

NameEmailPhoneSocials
See all 10 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$500k–$9M
Series A
$600k–$41M
Venture - Series Unknown
$1.2M–$24M

Investment Focus

Industry

  • Biotechnology 25 (21%)
  • Health Care 17 (14%)
  • Agriculture 16 (14%)
  • Software 14 (12%)
  • AgTech 13 (11%)
See all 93 industries →

Stage

  • Seed 20 (17%)
  • Series A 18 (15%)
  • Venture - Series Unknown 15 (13%)
  • Series B 14 (12%)
  • Series C 4 (3%)
See all 10 stages →

Country

  • United States 54 (46%)
  • Canada 2 (2%)
  • Australia 1 (1%)
  • New Zealand 1 (1%)

Team

NameTitleInvestmentsLinksEmail
Ken Harrington
Ken Harrington Selection Committee
Selection Committee Total investments: 0
Find email
Bobby Sandage
Bobby Sandage Member of Selection Committee
Member of Selection Committee Total investments: 2
Find email
Carter Williams
Carter Williams CEO and Managing Director
CEO and Managing Director Total investments: 26
Find email
Craig Herron
Craig Herron Managing Director
Managing Director Total investments: 45
Find email
COO Total investments: 0
Find email
See all 10 team members →

Investments

CompanyDescriptionRoundLinks
Miraterra's solution produces lab-quality findings in soil labs, the field, and the ground. Miraterra's accurate measurements, advanced reporting, and verification technologies will enable a new era of precision agriculture and carbon market credibility. $11.6M / Seed / Mar 25, 2026
Vive Crop Protection makes effective and sustainable pesticides for organic and non-organic production. The company creates new ways to use proven crop protection products using their targeted Allosperse Delivery System, which improves the targeting and performance of pesticide active ingredients. This helps farmers do more with less, all whileincreasing crop quality and yields.Vive Crop Protection was founded in 2006 and is headquartered in Mississauga, Ontario, Canada. $10M / Venture - Series Unknown / Oct 07, 2025
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.It has developed a process that uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell – known as extracellular vesicles, or EVs – to detect stage I cancer.Paul Blavin and Joseph Sedlak founded the Natick, Massachusetts-based company in 2018. $59M / Series B / Sep 03, 2025
Biodesigned proteins for beauty, wellness and beyond. Venture - Series Unknown / Aug 07, 2025
Growers Edge offers financial products and data-driven tools designed for agricultural retailers and manufacturers. The company focuses on providing solutions that enhance risk management and facilitate the adoption of new technologies in farming practices. By leveraging data science, Growers Edge helps its clients optimize their operations andimprove service delivery to growers. The platform aims to create a comprehensive fintech environment tailored specifically for the agricultural sector, addressing the unique challenges faced by its users. Through these offerings, Growers Edge supports the growth and efficiency of agricultural businesses. $29.2M / Venture - Series Unknown / Apr 29, 2025
BioLumic develops light signals that activate plant growth and unlock the natural genetic potential of crops. The company's photogenics platform leverages innovation in plant science, light technology and genetic insights. Demonstrated results include higher yield, improved vigor, increased disease and pest resistance, and improvements incrops composition. These results have been across a variety of seeds and seedling: soybean, cannabis and vegetable and fruit crops. It is a clean technology that does not require the use of chemicals or amendments. BioLumic is a private company and was founded in 2013. $8.3M / Series B / Apr 22, 2025
Edacious is a Public Benefit Corporation that develops a radical transparency-based food verification system. $8.1M / Seed / Feb 06, 2025
BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States. $27M / Series A / Dec 12, 2024
GroundTruth Ag is a soil cloud creator specializing in sustainable agricultural management. GroundTruth offers insights into soil management and health as well as near-real-time actionable data layers that cover the physical, chemical, and biological characteristics of the soil. This technology allows farmers to obtain accurate soil informationwhile also offering carbon creditors low-cost, hyper-accurate verification. $24M / Venture - Series Unknown / Nov 19, 2024
Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems. The company's platform delivers microbiome-based therapeutics to patients and the marketplace by treating depression, anxiety, and other mental health problems including our metabolism and the immune response,enabling patients to recover quickly from their diseases easily without any pain and suffering.Holobiome was established in 2015 and is based in Cambridge, Massachusetts. $9M / Seed / Oct 09, 2024
See all 118 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Honduras
Iceland
Grenada
Liechtenstein
Lebanon
Lithuania
Cambodia
Slovenia
Mongolia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does iSelect Fund invest in?

iSelect Fund invests primarily in Biotechnology, Health Care and Agriculture startups, most often at Seed and Series A stage. Most of the 118 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does iSelect Fund invest in?

iSelect Fund typically joins rounds of $500k–$9M at Seed, $600k–$41M at Series A and $1.2M–$24M at Venture - Series Unknown. These are whole funding-round sizes, not iSelect Fund's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds iSelect Fund took part in.

How do I contact iSelect Fund?

Public channels for iSelect Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at iSelect Fund?

The team at iSelect Fund includes Ken Harrington (Selection Committee), Bobby Sandage (Member of Selection Committee) and Carter Williams (CEO and Managing Director), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
iSelect Fund iSelect Fund Find emails